These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12723846)

  • 21. Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study.
    Huxley P; Evans S; Madge S; Webber M; Burchardt T; McDaid D; Knapp M
    Health Technol Assess; 2012; 16(1):iii-vii, ix-xii, -1-241. PubMed ID: 22260923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and initial validation of primary care provider mental illness management and team-based care self-efficacy scales.
    Loeb DF; Crane LA; Leister E; Bayliss EA; Ludman E; Binswanger IA; Kline DM; Smith M; deGruy FV; Nease DE; Dickinson LM
    Gen Hosp Psychiatry; 2017; 45():44-50. PubMed ID: 28274338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A national survey of care for persons with co-occurring mental and substance use disorders.
    Watkins KE; Burnam A; Kung FY; Paddock S
    Psychiatr Serv; 2001 Aug; 52(8):1062-8. PubMed ID: 11474052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community support services and functioning of the seriously mentally ill.
    Baker F; Jodrey D; Intagliata J; Straus H
    Community Ment Health J; 1993 Aug; 29(4):321-31. PubMed ID: 8375138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument.
    Mestre-Pintó JI; Domingo-Salvany A; Martín-Santos R; Torrens M;
    Eur Addict Res; 2014; 20(1):41-8. PubMed ID: 23921461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The New York State community support system: a profile of clients.
    Baker F; Intagliata J
    Hosp Community Psychiatry; 1984 Jan; 35(1):39-44. PubMed ID: 6693076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of persons with severe mental illness and substance abuse in rural areas.
    Barry KL; Fleming MF; Greenley JR; Kropp S; Widlak P
    Psychiatr Serv; 1996 Jan; 47(1):88-90. PubMed ID: 8925354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social exclusion in clients with comorbid mental health and substance misuse problems.
    Todd J; Green G; Harrison M; Ikuesan BA; Self C; Pevalin DJ; Baldacchino A
    Soc Psychiatry Psychiatr Epidemiol; 2004 Jul; 39(7):581-7. PubMed ID: 15243697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A SAMHSA research initiative assessing the effectiveness of jail diversion programs for mentally ill persons.
    Steadman HJ; Deane MW; Morrissey JP; Westcott ML; Salasin S; Shapiro S
    Psychiatr Serv; 1999 Dec; 50(12):1620-3. PubMed ID: 10577883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fidelity and outcomes in six integrated dual disorders treatment programs.
    Chandler DW
    Community Ment Health J; 2011 Feb; 47(1):82-9. PubMed ID: 19771518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery Assessment Scale: Testing validity with Portuguese community-based mental health organization users.
    Jorge-Monteiro MF; Ornelas JH
    Psychol Assess; 2016 Mar; 28(3):e1-11. PubMed ID: 26121387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ensuring integrated treatment for people with mental health and substance use problems.
    Hamilton I
    Nurs Times; 2010 Mar 23-29; 106(11):12-5. PubMed ID: 20391836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depressive symptoms and mentally ill chemical abusers' perception of the treatment environment in residential settings.
    Nuttbrock LA; Rahav MR; Rivera JJ; Ng-Mak DS
    Addict Behav; 1999; 24(1):139-44. PubMed ID: 10189982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment approaches for dual diagnosis clients in England.
    Schulte SJ; Meier PS; Stirling J; Berry M
    Drug Alcohol Rev; 2008 Nov; 27(6):650-8. PubMed ID: 18830860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severely and persistently mentally ill substance abusers: clinical and policy issues.
    Zweben JE
    J Psychoactive Drugs; 2000; 32(4):383-9. PubMed ID: 11210200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of alcohol and other drug disorders in the seriously mentally ill.
    Barry KL; Fleming MF; Greenley J; Widlak P; Kropp S; McKee D
    Schizophr Bull; 1995; 21(2):313-21. PubMed ID: 7631177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics.
    Gotham HJ; Claus RE; Selig K; Homer AL
    J Subst Abuse Treat; 2010 Mar; 38(2):160-9. PubMed ID: 19717273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seeking mental health care from private health practitioners among individuals with alcohol dependence/abuse; results from a study in the French general population.
    Constant A; Sherlaw W; Kovess-Masfety V
    Alcohol; 2017 Mar; 59():1-6. PubMed ID: 28262183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.